These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

364 related items for PubMed ID: 23361434

  • 1. Efficacy of herpes virus helicase-primase inhibitor, ASP2151, for treating herpes simplex keratitis in mouse model.
    Sasaki S, Miyazaki D, Haruki T, Yamamoto Y, Kandori M, Yakura K, Suzuki H, Inoue Y.
    Br J Ophthalmol; 2013 Apr; 97(4):498-503. PubMed ID: 23361434
    [Abstract] [Full Text] [Related]

  • 2. Effect of ASP2151, a herpesvirus helicase-primase inhibitor, in a guinea pig model of genital herpes.
    Katsumata K, Chono K, Sudo K, Shimizu Y, Kontani T, Suzuki H.
    Molecules; 2011 Aug 25; 16(9):7210-23. PubMed ID: 21869749
    [Abstract] [Full Text] [Related]

  • 3. ASP2151, a novel helicase-primase inhibitor, possesses antiviral activity against varicella-zoster virus and herpes simplex virus types 1 and 2.
    Chono K, Katsumata K, Kontani T, Kobayashi M, Sudo K, Yokota T, Konno K, Shimizu Y, Suzuki H.
    J Antimicrob Chemother; 2010 Aug 25; 65(8):1733-41. PubMed ID: 20534624
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effects of anti herpetic drugs on mice with herpetic epithelial keratitis after reactivation of herpes simplex virus type 1.
    Itahashi M, Higaki S, Shimomura Y.
    Semin Ophthalmol; 2008 Aug 25; 23(4):241-7. PubMed ID: 18584562
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of ASP2151, a helicase-primase inhibitor, against thymidine kinase-deficient herpes simplex virus type 2 infection in vitro and in vivo.
    Himaki T, Masui Y, Chono K, Daikoku T, Takemoto M, Haixia B, Okuda T, Suzuki H, Shiraki K.
    Antiviral Res; 2012 Feb 25; 93(2):301-304. PubMed ID: 22155691
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of a helicase-primase inhibitor in animal models of ocular herpes simplex virus type 1 infection.
    Kaufman HE, Varnell ED, Gebhardt BM, Thompson HW, Atwal E, Rübsamen-Waigmann H, Kleymann G.
    J Ocul Pharmacol Ther; 2008 Feb 25; 24(1):34-42. PubMed ID: 18201137
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Profile of anti-herpetic action of ASP2151 (amenamevir) as a helicase-primase inhibitor.
    Yajima M, Yamada H, Takemoto M, Daikoku T, Yoshida Y, Long T, Okuda T, Shiraki K.
    Antiviral Res; 2017 Mar 25; 139():95-101. PubMed ID: 28027917
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics and pharmacodynamics of ASP2151, a helicase-primase inhibitor, in a murine model of herpes simplex virus infection.
    Katsumata K, Chono K, Kato K, Ohtsu Y, Takakura S, Kontani T, Suzuki H.
    Antimicrob Agents Chemother; 2013 Mar 25; 57(3):1339-46. PubMed ID: 23274658
    [Abstract] [Full Text] [Related]

  • 12. Susceptibility of herpes simplex virus isolated from genital herpes lesions to ASP2151, a novel helicase-primase inhibitor.
    Katsumata K, Weinberg A, Chono K, Takakura S, Kontani T, Suzuki H.
    Antimicrob Agents Chemother; 2012 Jul 25; 56(7):3587-91. PubMed ID: 22526302
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Synergistic activity of amenamevir (ASP2151) with nucleoside analogs against herpes simplex virus types 1 and 2 and varicella-zoster virus.
    Chono K, Katsumata K, Suzuki H, Shiraki K.
    Antiviral Res; 2013 Feb 25; 97(2):154-60. PubMed ID: 23261844
    [Abstract] [Full Text] [Related]

  • 17. [Herpes simplex virus latency, reactivation, and a new antiviral therapy for herpetic keratitis].
    Shimomura Y.
    Nippon Ganka Gakkai Zasshi; 2008 Mar 25; 112(3):247-64; discussion 265. PubMed ID: 18411713
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Herpes simplex virus helicase-primase inhibitors are active in animal models of human disease.
    Crute JJ, Grygon CA, Hargrave KD, Simoneau B, Faucher AM, Bolger G, Kibler P, Liuzzi M, Cordingley MG.
    Nat Med; 2002 Apr 25; 8(4):386-91. PubMed ID: 11927945
    [Abstract] [Full Text] [Related]

  • 20. [Battle with herpes for 37 years].
    Shimomura Y.
    Nippon Ganka Gakkai Zasshi; 2015 Mar 25; 119(3):145-66; discussion 167. PubMed ID: 25854108
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.